Richard C. Mulligan
Director and Chair
Neuroscience
Biogen
Greece
Biography
Richard C. Mulligan, Ph.D., joined our Board of Directors in 2009. Dr. Mulligan serves as Chair of our Science and Technology Committee and is a member of our Compensation and Management Development Committee. Dr. Mulligan is a Portfolio Manager at Icahn Capital LP and, since 2013, the Mallinckrodt Professor of Genetics, Emeritus, at Harvard Medical School, after serving as the Mallinckrodt Professor of Genetics and Director of the Harvard Gene Therapy Initiative since 1996.
Research Interest
He was a member of the Whitehead Institute for Biomedical Research and the Chief Scientific Officer of Somatix Therapy Corporation, a drug discovery and development company that he founded. His research interest include the area of moleculer biology
